Articles by rhankins

No Picture
Boston Cambridge Biotech Trending News

Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer

June 17, 2021 rhankins Comments Off on Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer

LEXINGTON, Mass., June 17, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents which includes checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response […]

No Picture
Boston Cambridge Biotech Trending News

Professor Emeritus Edward Merrill, chemical engineer who helped found the field of bioengineering, dies at 96

June 10, 2021 rhankins Comments Off on Professor Emeritus Edward Merrill, chemical engineer who helped found the field of bioengineering, dies at 96

Edward W. Merrill, professor emeritus of chemical engineering, died peacefully at his home on Aug. 6 at the age of 96, surrounded by his children and grandchildren. A longtime chemical engineer at MIT, Merrill was […]

No Picture
Boston Cambridge Biotech Trending News

Theseus Pharmaceuticals Appoints Kathy Yi to Board of Directors and Chair of Audit Committee

June 10, 2021 rhankins Comments Off on Theseus Pharmaceuticals Appoints Kathy Yi to Board of Directors and Chair of Audit Committee

CAMBRIDGE, Mass.: CAMBRIDGE, Mass., June 10, 2021 /PRNewswire/ — Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the appointment of Kathy Yi, Chief Financial […]